Intellectual Property UK

  • May 02, 2024

    McNeil Again Denied Patent On Spray Nicotine Treatment

    A Kenvue-owned pharmaceutical company has failed to patent a tobacco replacement therapy, after European patent officials ruled that other scientists would have thought of adding a special solution to counteract the slowing effects of saliva pH.

  • May 02, 2024

    IBM Director Grilled Over Reverse Engineering Allegations

    An IBM director faced questions on Thursday about his role in accusing a tech rival of breaching its customer agreement by claiming it reverse-engineered IBM software, with lawyers for the rival arguing he improperly terminated the customer contract.

  • May 02, 2024

    InterDigital Claims Munich Court Win In Lenovo SEP Spat

    InterDigital said Thursday it has secured an injunction against Lenovo in Germany, with a Munich court ruling that Lenovo infringed an InterDigital patent deemed essential to 4G and 5G technology and was unwilling to agree to a fair license.

  • May 02, 2024

    Truck Aerodynamics Co. Sues Over Amazon Deal Loss

    A truck aerodynamics company has accused a rival of modifying products that were being tested by Amazon, leading them to perform poorly and causing the company to lose out on a million-pound contract.

  • May 02, 2024

    Universal Music Allows Artists Back On TikTok After Deal

    Universal Music Group has reached a deal with TikTok that will allow its affiliated artists and music to return to the social media platform months after the companies fell out over issues of artist compensation and artificial intelligence-generated content.

  • May 02, 2024

    Bayer Sues Dr. Reddy's In Latest Xarelto Patent Clash

    Bayer has accused generic drugmaker Dr. Reddy's of selling blood thinning medication that infringes a dosage patent over its blockbuster drug Xarelto, marking the latest attempt by the pharmaceutical giant to stop challenges to its market share.

  • May 01, 2024

    Abbott Wants Sales Of Rival Glucose Monitor Barred For Now

    A subsidiary of Abbott Laboratories urged a London court Wednesday to bar medical devices rival Sinocare Inc. from mass marketing a glucose monitoring system that it argues is highly similar to a trademark for one of its own products.

  • May 01, 2024

    Bayer Gets Chance To Appeal Xarelto Patent Loss

    Bayer AG can appeal a High Court decision that nixed a patent for its blockbuster drug Xarelto in the U.K., the U.K. judiciary confirmed on Wednesday.

  • May 01, 2024

    10x Genomics Gets Injunction Against Rival's DNA Kit

    Curio Bioscience must immediately stop selling a version of its spatial mapping kits used for DNA and RNA analysis of tissue samples, after the Unified Patent Court ruled they might be infringing on 10x Genomics' patent.

  • May 01, 2024

    Social Media Marketing Biz Scores Partial TM Win In UK

    A social media marketing firm using the logo "Goat" has succeeded in part in invalidating a trademark applied for by a dance company using the same word, with the intellectual property regulator finding that consumers may be deceived into thinking the dance company is linked to the larger film company.

  • May 01, 2024

    Game Developer Denies Copying Rival's 'Generic' Racing App

    A British game developer has hit back at its French rival in a copyright feud over the pair's mobile games, telling a London court that any similarities between the apps are nondistinctive features that don't merit protection.

  • May 01, 2024

    MPs Call For New AI Laws To Protect Music Industry

    A group of MPs said Wednesday that they are calling on Parliament to introduce tougher laws on artificial intelligence, with a focus on preventing generative AI programs from stealing from musicians and others in creative industries.

  • April 30, 2024

    Target's Bid To Register Bullseye TM In EU Misfires

    Target has failed to register a European Union trademark over its iconic red and white bullseye logo after the bloc's officials ruled that its two "banal and simple geometric shapes" weren't distinctive.

  • April 30, 2024

    Payment Co. Hits Back Over Failed Domain Name Deal

    Several payments companies and their bosses have hit back at claims by a Nuvei Group subsidiary, denying that they broke a promise to use the company's payments technology as part of a deal to use a website domain.

  • April 30, 2024

    Rival Denies Using IBM Software Secrets At London Trial

    Tech company LZLABS denied allegations that it reverse-engineered proprietary technology owned by IBM, telling a London judge Tuesday that its software was not developed using any inner workings or hidden secrets of IBM programs.

  • April 30, 2024

    Backing For Concord's $1.5B Hipgnosis Bid Falls

    Support for music rights company Concord Chorus' $1.5 billion bid for rival Hipgnosis Songs Fund Ltd. dropped among the latter's shareholders on Tuesday, after private equity giant Blackstone swooped in with an improved $1.6 billion offer.

  • April 30, 2024

    Mercedes-Benz Loses Race Against 'Vivo' Self-Driving Car TM

    Auto giant Mercedes-Benz has lost its bid to prevent a self-driving car company from registering its "Vivo" logo, as the U.K. intellectual property authority found that it is not meaningfully similar to Mercedes' own "Vito" brand.

  • April 29, 2024

    German Pharma Biz Can't Block Rival's 'Palmea' TM In EU

    A German pharmaceutical company can't reverse a competitor's "Palmea" trademark protections in the European Union because its earlier "mea" family of marks isn't sufficiently similar to create a risk of confusion, an appeals panel in the bloc said in a ruling made public Monday.

  • April 29, 2024

    Board Backs German Winery's Appeal Against 'Grizzly' TM

    A German winery has beaten a rival's bid to register the trademark "Grizzly" over alcohol drink preparations, with European officials ruling that the winery's earlier "Grizzly Bear" sign over spirits also covers premix ingredients.

  • April 29, 2024

    Tech Co.'s 'Fraud Fighters' TM Too Descriptive

    An antifraud tech company failed to register a trademark for "Fraud Fighters," after European officials ruled it was "nothing more than the sum of its parts" describing the goods it covered.

  • April 29, 2024

    Hotel Group Blocks Candlemaker's TM Over Confusion Risks

    A French hotel chain has persuaded the U.K.'s intellectual property office to refuse a trademark for a company selling scented candles because consumers might mistake the hotel's berry branch trademark for a line of the candlemaker's berry-scented products.

  • April 29, 2024

    IBM Targets Rival For Reverse Engineering Code At Trial

    Computer giant IBM accused European rival LzLabs at the beginning of a nine-week trial Monday of violating its consumer agreement, saying the competitor's "reverse engineering" of some of its software is a breach of contract.

  • April 29, 2024

    Hipgnosis Backs Blackstone's New $1.6B Offer In Bidding War

    Blackstone said on Monday that the directors of music rights company Hipgnosis Songs will back a new $1.6 billion offer by the private equity giant after they said they would withdraw their backing for an earlier $1.5 billion bid from a U.S. competitor, Concord Chorus.

  • April 26, 2024

    Skechers Loses Bid To Register 'Just Slip In' TM

    American sneakers giant Skechers has lost its fight to win trademark protection for its "Just Slip In" slogan, with a European patent authority appeal board concluding that the phrase merely describes the shoes.

  • April 26, 2024

    Coca-Cola Chews Up Greek Rival's 'Tsakiris' Snack TM

    A Coca-Cola subsidiary defeated a rival that wanted to register the trademark "Tsakiris" to sell cereal snacks, after a European court ruled that it would take unfair advantage of the soft drink giant's reputation in Greek potato chips.

Expert Analysis

  • English Could Be The Future Language Of The UPC

    Author Photo

    While most Unified Patent Court proceedings are currently held in German, the recent decisions in Plant-e v. Arkyne and Amgen v. Sanofi potentially signal that English will be the preferred language, particularly in cases involving small and medium enterprises, say lawyers at Freshfields.

  • Arbitration Remains Attractive For Digital Disputes In 2024

    Author Photo

    Recent regulatory and digital forum developments highlight that, in 2024, arbitration will continue to adapt to new technologies, such as artificial intelligence and cryptocurrency, and remain an attractive forum for resolving digital disputes due to its flexibility, confidentiality and comparative ease to enforce cross-border awards, says Peter Smith at Charles Russell.

  • US And UK Law Firms Continue Trend Of EU Expansion

    Author Photo

    A broad spectrum of U.S. and U.K. law firms are now seeking fresh opportunities in Europe's fastest growing and constantly evolving sectors by opening offices in strategic locations across the continent, says James Lavan at Buchanan Law.

  • Looking Ahead At AI Regulation In The EU And UK

    Author Photo

    With AI regulation agreed upon in Europe and a U.K. regulatory authority on the horizon, organizations developing AI should consider deploying governance, addressing accountability and establishing internal guardrails to achieve a balanced approach to responsible innovation while managing risk, says Chris Eastham at Fieldfisher.

  • 2024 Will Be A Busy Year For Generative AI And IP Issues

    Author Photo

    In light of increased litigation and policy proposals on balancing intellectual property rights and artificial intelligence innovation, 2024 is shaping up to be full of fast-moving developments that will have significant implications for AI tool developers, users of such tools and rights holders, say lawyers at Mishcon de Reya.

  • The Most-Read Law360 UK Guest Articles Of 2023

    Author Photo

    Benefits of the new EU Unified Patent Court, artificial intelligence regulation and M&A trends amid rising inflation were among the hot topics U.K. Expert Analysis articles explored this year.

  • 9 Takeaways From The UPC's First 6 Months In Session

    Author Photo

    Six months after its opening, the Unified Patent Court has established itself as an appealing jurisdiction, with its far territorial reach, short filing deadlines and extremely quick issuance of preliminary injunctions showing that it is well-prepared to provide for rapid legal clarity, says Antje Brambrink at Finnegan.

  • The Year In FRAND: What To Know Heading Into 2024

    Author Photo

    In 2023, there were eight significant developments concerning the fair, reasonable and nondiscriminatory patent licensing regime that undergirds technical standardization, say Tom Millikan and Kevin Zeck at Perkins Coie.

  • How Int'l Student-Athlete Law Would Change The NIL Game

    Author Photo

    Recently proposed legislation to allow international student-athletes the opportunity to profit from their name, image and likeness without violating their F-1 nonimmigrant student visa status represents a pivotal step in NIL policy, and universities must assess and adapt their approaches to accommodate unique immigration concerns, say attorneys at Phelps Dunbar.

  • Series

    Children's Book Writing Makes Me A Better Lawyer

    Author Photo

    Becoming a children's book author has opened doors to incredible new experiences of which I barely dared to dream, but the process has also changed my life by serving as a reminder that strong writing, networking and public speaking skills are hugely beneficial to a legal career, says Shaunna Bailey at Sheppard Mullin.

  • How The PTAB Landscape Shifted In 2023

    Author Photo

    Attorneys at Finnegan consider the impact of noteworthy Patent Trial and Appeal Board developments in 2023, including rulemaking, litigation, precedential decisions and director reviews that affected PTAB practice, and offer a reference for examining future proceedings and strategies.

  • How 'Copyleft' Licenses May Affect Generative AI Output

    Author Photo

    Open-source software and the copyleft licenses that support it, whereby derivative works must be made available for others to use and modify, have been a boon to the development of artificial intelligence, but could lead to issues for coders who use AI to help write code and may find their resulting work exposed, says William Dearn at HLK.

  • UPC Decision Highlights Key Security Costs Questions

    Author Photo

    While the Unified Patent Court recently ordered NanoString to pay €300,000 as security for Harvard's legal costs in a revocation action dispute, the decision highlights that the outcome of a security for costs application will be highly fact-dependent and that respondents should prepare to set out their financial position in detail, says Tom Brazier at EIP.

  • IP Ruling Could Pave Way For AI Patents In UK

    Author Photo

    If implemented by the U.K. Intellectual Property Office, the High Court's recent ruling in Emotional Perception AI v. Comptroller-General of Patents, holding that artificial neural networks can be patented, could be a first step to welcoming AI patents in the U.K., say Arnie Francis and Alexandra Brodie at Gowling.

  • Why It's Urgent For Pharma Cos. To Halt Counterfeit Meds

    Author Photo

    With over 10.5 million counterfeit medicines seized in the EU in 2023, it is vital both ethically and commercially that pharmaceutical companies take steps to protect against such infringements, including by invoking intellectual property rights protection, says Lars Karnøe at Potter Clarkson.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!